Peptide YY augments gross inhibition by vitamin E succinate of human pancreatic cancer cell growth

Journal of Surgical Research

Volumn 88, Issue 1, 2000, Pages 23-25

  Heisler, Tracy ^a,b   Towfigh, Shirin ^a,b   Simon, Natalie ^a,b   Liu, Carson ^a,b   McFadden, David W ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UCLA MEDICAL CENTER   (United States)

Author keywords

Pancreatic cancer; Peptide YY; Vitamin E succinate

Indexed keywords

ALPHA TOCOPHEROL SUCCINATE; PEPTIDE YY;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER GROWTH; CELL VIABILITY; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; PANCREAS CANCER; PRIORITY JOURNAL;

EID: 0033969552     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1999.5775     Document Type: Article

References (18)

1. Surveillance, Epidemiology, and End Results Program. 1997
2. Surveillance Research. 1998
3. Kalser M. H., Ellenberg S. S. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch. Surg. 120:1985;899
4. Tatemoto K., Nakano I., Makk G., Angwin P., Mann M., Schilling J., Go V. L. Isolation and primary structure of human peptide YY. Biochem. Biophys. Res. Commun. 157:1988;713
5. Böttcher G., Sjöberg J., Ekman R., Håkanson R., Sundler F. Peptide YY in the mammalian pancreas: Immunocytochemical localization and immunochemical characterization. Regul. Pept. 43:1993;115
6. Brodish R. J., Kuvshinoff B. W., Fink A. S., McFadden D. W. Effects of intraluminal peptide YY on pancreatic function. Int. J. Pancreatol. 12:1992;153
7. Brodish R. J., Kuvshinoff B. W., Fink A. S., McFadden D. W. Peptide YY inhibits pancreatic secretion via cholinergic pathways. J. Surg. Res. 55:1993;103
8. Liu C. D., Balasubramaniam A., Saxton R. E., Paiva M., McFadden D. W. Human pancreatic cancer growth is inhibited by peptide YY and BIM-43004-1. J. Surg. Res. 58:1995;707
9. Eberlein G. A., Eysselein V. E., Schaeffer M., Layer P., Grandt D., Goebell H., Niebel W., Davis M., Lee T. D., Shively J. E. A new molecular form of PYY: Structural characterization of human PYY(3-36) and PYY(1-36). Peptides. 10:1989;797
10. Liu C. D., Slice L. W., Balasubramaniam A., Walsh J. H., Newton T. R., Saxton R. E., McFadden D. W. Y2 receptors decrease human pancreatic cancer growth and intracellular cyclic adenosine monophosphate levels. Surgery. 118:1995;229
11. Steinmetz K. A., Potter J. D. Vegetables, fruit, and cancer prevention: A review. J. Am. Diet. Assoc. 96:1996;1027
12. Israel K., Sanders B. G., Kline K. RRR-alpha-tocopheryl succinate inhibits the proliferation of human prostatic tumor cells with defective cell cycle/differentiation pathways. Nutr. Cancer. 24:1995;161
13. Prasad K. N. Mechanisms of action of vitamin E on mammalian tumor cells in culture. Prog. Clin. Biol. Res. 259:1988;363
14. Yu W., Israel K., Liao Q. Y., Aldaz C. M., Sanders B. G., Kline K. Vitamin E succinate (VES) induces Fas sensitivity in human breast cancer cells: Role for Mr 43, 000 Fas in VES-triggered apoptosis. Cancer Res. 59:1999;953
15. Carmichael J., DeGraff W. G., Gazdar A. F., Minna J. D., Mitchell J. B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing. Cancer Res. 47:1987;936
16. McHale A. P., McHale L. Use of a tetrazolium based colorimetric assay in assessing photoradiation therapy in vitro. Cancer Lett. 41:1988;315
17. Prasad K. N., Edwards-Prasad J. Vitamin E and cancer prevention: Recent advances and future potentials [see comments]. J. Am. Coll. Nutr. 11:1992;487
18. Yu W., Simmons-Menchaca M., You H., Brown P., Birrer M. J., Sanders B. G., Kline K. RRR-alpha-tocopheryl succinate induction of prolonged activation of c-jun amino-terminal kinase and c-jun during induction of apoptosis in human MDA-MB-435 breast cancer cells. Mol. Carcinog. 22:1998;247